≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_LUNG_NEUROENDO_EXALLC for full statistics.

Neuroendocrine tumor and carcinoma of lung

Endpoint Browser

C3_LUNG_NEUROENDO

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 — C34
  • Cancer registry: Morphology ICD-O-3 — 8240|8246|8249
  • Cancer registry: Behaviour codes — 3

1 out of 7 registries used, show all original rules.

259

4. Check minimum number of events

None

259

5. Include endpoints

None

259

6. Filter based on genotype QC (FinnGen only)

259

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF9

Similar endpoints

↥

List of similar endpoints to Neuroendocrine tumor and carcinoma of lung based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 259 162 97
Unadjusted period prevalence (%) 0.05 0.06 0.04
Median age at first event (years) 64.80 64.11 65.96

-FinnGen-

Age distribution of first events

010304050607080010203040506070AgeIndividuals

-FinnGen-

Year distribution of first events

1985199019952000200520102015202020230102030405060708090100110YearIndividuals

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
232
Matched controls
2319
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
87.3
108.9
118
27
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
21.2
81.5
136
145
C34.37
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung carcinoid
+∞
75.2
68
*
C34.17
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary carcinoid
+∞
70.5
64
*
8240/3-C34.9
ICD-O-3
Neuroendocrine tumor, NOS, of lung, NOS
+∞
58.9
54
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
125.2
54.7
57
6
UGC12
NOMESCO Finland
Flexible bronchoscopy
14.4
53.2
99
114
8240/3-C34.3
ICD-O-3
Neuroendocrine tumor, NOS, of lower lobe, lung
+∞
49.8
46
*
GDC00
NOMESCO Finland
Lobectomy of lung
174.8
42.3
43
*
8240/3-C34.1
ICD-O-3
Neuroendocrine tumor, NOS, of upper lobe, lung
+∞
33.1
31
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
10.5
27.4
56
68
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
17.5
25.9
41
28
C34.27
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung carcinoid
+∞
25.5
24
*
8246/3-C34.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of lung, NOS
+∞
24.4
23
*
WZC30
NOMESCO Finland
Teaching
5.6
22.3
74
180
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.1
21.9
163
854
C34.97
ICD-10 Finland
Malignant tumor in unspecified location in bronchial and pulmonary carcinoid
+∞
20.1
19
*
130
Kela drug reimbursment
Malignant tumour
6.0
19.2
57
119
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.3
17.4
74
227
8246/3-C34.1
ICD-O-3
Neuroendocrine carcinoma, NOS, of upper lobe, lung
+∞
16.9
16
*
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
97.2
16.8
18
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
48.5
15.3
18
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
34.3
15.1
19
6
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.3
15.0
37
59
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
22.9
14.9
21
10
8240/3-C34.2
ICD-O-3
Neuroendocrine tumor, NOS, of middle lobe, lung
+∞
14.7
14
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
79.9
13.7
15
*
8249/3-C34.3
ICD-O-3
Neuroendocrine tumor, grade 2 of lower lobe, lung
+∞
13.7
13
*
N02AX02
ATC
tramadol; systemic, rectal
2.9
13.6
127
680
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
24.2
13.1
18
8
8249/3-C34.1
ICD-O-3
Neuroendocrine tumor, grade 2 of upper lobe, lung
+∞
12.6
12
*
C34.87
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary carcinoid
+∞
12.6
12
*
TGD00
NOMESCO Finland
Needle biopsy of lung
137.1
12.6
13
*
L01CB01
ATC
etoposide; systemic
49.4
12.0
14
*
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
24.4
11.7
16
7
B01AB05
ATC
enoxaparin; parenteral
2.7
11.3
101
510
R4110
NOMESCO Finland
Physiotherapy
2.8
11.1
88
411
N03AX16
ATC
pregabalin; oral
2.9
10.9
83
379
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.2
10.9
34
74
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
29.6
10.9
14
5
GD1AD
NOMESCO Finland
Thorax CT examination
5.6
10.6
31
62
JN4CD
NOMESCO Finland
Very extensive body CT
6.5
9.8
25
42
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
57.4
9.7
11
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
57.4
9.7
11
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
104.1
9.5
10
*
R03BB04
ATC
tiotropium bromide; inhalant
3.6
9.4
45
147
R03AK08
ATC
formoterol and beclometasone; inhalant
7.2
9.4
22
33
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.0
9.2
22
34
WF049
NOMESCO Finland
Radiotherapy of metastasis
6.6
8.9
22
36
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
+∞
8.4
8
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
8.3
73
351
E34.0
ICD-10 Finland
Carcinoid syndrome
34.7
8.1
10
*
WX402
NOMESCO Finland
General anaesthesia
2.8
8.0
55
231
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.4
7.6
38
128
D14.3
ICD-10 Finland
Benign neoplasm: Bronchus and lung
82.6
7.5
8
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
6.2
7.4
19
33
JN4BD
NOMESCO Finland
Extensive body CT
3.0
7.3
44
166
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.5
6.9
32
102
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
6.8
81
449
R84
ICPC
Malignant neoplasm bronchus/lung
23.3
6.7
9
*
R03AC02
ATC
salbutamol; inhalant
2.1
6.7
133
916
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
6.7
64
320
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
71.7
6.5
7
*
GDA20
NOMESCO Finland
Excision of lesion of lung
71.7
6.5
7
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.7
6.4
27
80
C34.07
ICD-10 Finland
Malignant tumor of the main bronchus carcinoid
+∞
6.3
6
*
8246/3-C34.3
ICD-O-3
Neuroendocrine carcinoma, NOS, of lower lobe, lung
+∞
6.3
6
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
6.3
6
*
GDC20
NOMESCO Finland
Lobectomy of lung and sleeve resection of bronchus
+∞
6.3
6
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
27.5
6.3
8
*
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
27.5
6.3
8
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
61
10
79.48
112.31
5.2
3.8
144.59
78.90
nmol/l
—
61
10
103
208
7.56
53.54
1.5
1.3
—
—
—
0
0
89
273
4.44
26.83
1.5
1.3
—
—
—
0
0
165
911
3.24
18.50
6.9
8.9
1.16
1.23
inr
0.51
39
271
194
1274
3.08
14.31
10.5
8.8
4.22
4.05
e9/l
0.50
176
1123
130
716
2.64
13.20
6.5
5.2
—
—
—
0
0
22
36
6.59
13.16
2.1
3.4
—
—
—
0
0
64
249
3.09
12.55
2.6
4.2
26.09
24.33
ug/l
0.02
56
211
158
975
2.59
12.40
6.7
5.5
0.70
0.68
%
0.20
153
906
127
708
2.56
12.36
5.0
3.7
7.40
7.40
ph
0.08
26
142
162
1013
2.60
12.35
6.6
5.8
8.96
8.66
%
0.66
157
949
161
1007
2.58
12.21
6.6
5.4
2.65
2.85
%
0.69
156
937
191
1298
2.80
12.20
6.2
4.8
6.98
6.70
mmol/l
1.01
183
1208
149
900
2.54
12.16
3.2
2.1
—
—
—
0
0
124
696
2.50
11.74
2.8
2.2
—
—
—
0
0
162
1029
2.53
11.69
6.6
5.6
26.00
27.70
%
1.17
156
957
168
1087
2.55
11.63
6.4
5.3
0.60
0.58
e9/l
0.58
148
945
170
1112
2.54
11.40
6.4
5.3
1.78
1.94
e9/l
0.73
151
988
168
1096
2.52
11.28
6.4
5.3
0.04
0.04
e9/l
0.51
148
951
170
1123
2.50
10.98
6.5
5.5
0.19
0.19
e9/l
0.06
152
991
157
1019
2.37
10.28
6.4
5.4
59.29
57.12
%
1.33
152
954
148
940
2.34
10.15
4.8
4.3
34.63
35.67
g/l
1.41
141
878
159
1044
2.35
10.05
7.8
5.7
1.22
1.22
mmol/l
0.28
151
937
60
257
2.74
9.69
7.9
8.4
1.14
1.30
mmol/l
0.14
55
209
101
560
2.32
9.36
6.7
6.3
—
—
—
0
0
165
1122
2.30
9.30
9.1
6.5
1.21
1.22
mmol/l
0.36
141
936
45
173
2.94
8.84
1.5
1.5
—
—
—
0
0
146
964
2.18
8.60
12.1
9.6
0.00
0.00
e9/l
0.46
115
791
47
189
2.82
8.50
1.5
1.5
—
—
—
0
0
217
1722
2.60
7.73
13.3
7.5
85.34
78.76
u/l
1.18
212
1614
12
18
6.94
7.67
3.7
1.5
—
—
—
0
0
30
106
3.07
6.79
12.7
12.9
—
—
—
0
0
41
172
2.64
6.79
11.7
7.4
—
—
—
0
0
119
784
1.96
6.47
4.8
3.2
2.39
2.36
mmol/l
1.57
108
681
99
621
1.96
6.14
5.0
4.0
—
—
—
0
0
39
176
2.43
5.53
4.8
6.5
8.59
9.79
mmol/l
0.61
39
164
13
30
4.51
5.36
1.0
1.0
—
—
—
0
0
49
258
2.11
4.82
3.2
5.1
1.00
1.03
mmol/l
0.40
49
240
188
1566
1.73
3.77
4.5
4.0
—
—
—
0
0
67
428
1.76
3.66
3.9
2.9
2.49
2.46
mmol/l
1.66
62
378
15
51
3.06
3.64
1.2
1.9
139.14
127.36
g/l
—
7
33
8
13
6.31
3.53
1.3
1.0
—
—
—
0
0
8
14
5.86
3.36
1.1
1.2
—
—
—
0
0
32
169
2.02
3.12
2.2
3.6
100.16
75.96
ng/l
1.40
32
151
10
30
3.43
2.93
1.1
2.2
92.04
89.03
%
—
10
30
93
681
1.57
2.93
3.7
3.1
25.93
144.48
e6/l
0.67
74
525
67
457
1.63
2.82
1.7
1.7
1.76
1.08
mg/l
0.79
55
360
82
588
1.58
2.81
3.7
3.0
—
—
—
0
0
32
176
1.93
2.79
3.3
4.3
0.09
0.10
%
0.02
11
51
13
48
2.80
2.76
2.8
2.8
3.74
4.83
e9/l
1.00
13
48
13
48
2.80
2.76
3.3
3.4
56.15
60.38
%
0.70
13
48
9
24
3.85
2.70
1.1
1.6
—
—
—
0
0
31
171
1.92
2.69
3.3
4.3
0.00
0.19
%
—
10
47
189
1638
1.57
2.63
5.1
4.1
15.27
12.92
mm/h
1.06
179
1487
72
508
1.58
2.62
1.3
1.3
—
—
—
0
0
20
94
2.22
2.62
5.2
3.7
24.91
24.25
mmol/l
0.47
20
84
6
11
5.55
2.55
1.2
1.0
—
—
—
0
0
33
192
1.82
2.44
1.6
2.4
75.27
69.70
e9/l
0.27
22
155
69
491
1.55
2.41
5.2
5.0
—
—
—
0
0
8
22
3.72
2.38
1.3
1.4
—
—
—
0
0
103
802
1.47
2.33
4.3
3.7
97.45
82.61
e6/l
0.12
80
565
6
13
4.70
2.28
1.3
1.2
—
—
—
0
0
32
189
1.79
2.26
3.3
4.2
0.64
0.70
%
0.07
11
58
9
30
3.07
2.17
1.1
3.1
—
—
—
0
0
13
55
2.44
2.16
1.0
1.1
—
—
—
0
0
82
622
1.47
2.09
3.8
3.0
0.64
0.47
e6/l
0.29
61
459
50
342
1.57
2.06
3.3
3.0
2.57
2.33
e6/l
0.05
26
192
29
172
1.77
2.03
3.3
4.0
0.25
0.38
%
—
8
42
8
26
3.14
2.03
1.3
1.0
—
—
—
0
0
6
16
3.81
1.94
2.2
5.6
—
—
—
0
0
58
419
1.50
1.87
3.8
3.7
615.50
163.76
ng/l
0.62
46
341
6
17
3.59
1.85
1.2
1.4
—
—
—
0
0
5
12
4.23
1.83
2.2
7.3
—
—
—
0
0
13
62
2.15
1.68
2.5
2.3
11.34
12.23
mg/l
0.17
13
57
5
14
3.62
1.62
3.0
1.5
1.10
1.03
g/l
—
5
14
6
20
3.05
1.59
1.2
1.2
—
—
—
0
0
228
2134
1.57
1.57
25.0
14.5
31.82
23.08
mg/l
2.97
215
1685
10
44
2.32
1.55
2.1
3.1
—
—
—
0
0
194
1763
1.40
1.55
31.2
17.7
14.10
13.76
%
2.07
194
1731
5
15
3.38
1.53
1.4
1.1
—
—
—
0
0
45
322
1.48
1.52
2.1
2.0
—
—
—
0
0
11
52
2.16
1.46
3.3
3.1
14.27
30.29
u/ml
0.65
11
52
5
16
3.16
1.44
1.2
2.2
—
—
—
0
0
30
199
1.57
1.43
4.4
3.8
—
—
—
0
0
6
24
2.53
1.31
1.5
1.1
—
—
—
0
0
9
44
2.08
1.28
1.7
2.8
—
—
—
0
0
28
188
1.55
1.28
4.5
3.8
—
—
—
0
0
13
71
1.87
1.21
2.5
3.3
—
—
—
0
0
8
38
2.14
1.19
2.0
1.7
56.25
62.16
%
—
8
38
7
30
2.37
1.13
1.3
1.4
—
—
—
0
0
7
30
2.37
1.13
1.3
1.4
—
—
—
0
0
7
30
2.37
1.13
1.3
1.4
—
—
—
0
0
202
1881
1.34
1.13
28.0
15.3
39.96
39.65
%
0.23
141
1304
8
40
2.03
1.13
1.1
1.6
—
—
—
0
0
10
51
2.00
1.12
2.7
1.4
0.93
0.82
nmol/l
—
10
40
7
31
2.29
1.11
1.3
1.4
—
—
—
0
0
50
622
0.76
0.98
3.8
5.0
1.49
2.15
ug/l
2.00
42
551
0
29
0.00
0.98
0.0
2.4
—
—
—
0
0
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
9
51
1.79
0.95
1.0
1.2
—
—
—
0
0
7
37
1.92
0.94
1.4
1.1
—
—
—
0
0
27
366
0.71
0.92
2.7
3.1
0.48
0.76
ug/l
3.57
18
246
6
29
2.09
0.90
1.3
1.4
—
—
—
0
0
8
44
1.84
0.86
1.1
1.3
—
—
—
0
0
102
896
1.23
0.85
3.5
4.0
20.53
34.58
ng/l
2.05
71
680
23
164
1.44
0.83
1.5
2.4
—
—
—
0
0
6
34
1.78
0.77
1.0
1.3
—
—
—
0
0
9
53
1.72
0.76
1.0
1.8
—
—
—
0
0
5
25
2.02
0.73
1.2
1.2
—
—
—
0
0
5
25
2.02
0.73
1.2
1.5
—
—
—
0
0
81
708
1.21
0.70
2.8
3.0
7.52
7.19
mmol/l
0.19
69
580
9
59
1.54
0.69
3.2
2.4
25.96
25.40
mmol/l
—
9
51
204
2126
0.81
0.66
4.6
4.7
1.40
1.51
mmol/l
3.16
189
1941
8
49
1.65
0.62
1.9
5.6
—
—
—
0
0
20
148
1.38
0.62
1.2
1.2
—
—
—
0
0
16
114
1.43
0.60
1.4
1.3
—
—
—
0
0
176
1662
1.18
0.60
4.1
4.0
14.62
14.90
pmol/l
0.77
162
1492
8
52
1.56
0.60
2.3
2.4
7.86
7.59
kpa
—
8
47
66
575
1.20
0.59
2.4
2.7
4243.82
8768.97
umol/l
0.48
57
490
211
2185
0.81
0.58
5.0
5.4
2.58
2.73
mmol/l
1.67
194
1993
36
294
1.26
0.58
21.4
21.6
1.08
1.41
inr
—
5
36
17
125
1.39
0.55
1.9
4.2
—
—
—
0
0
25
196
1.30
0.55
1.4
1.5
—
—
—
0
0
78
694
1.18
0.55
3.0
3.1
—
—
—
0
0
198
2058
0.84
0.54
4.1
4.2
1.42
1.28
mmol/l
2.05
179
1869
82
734
1.17
0.54
3.9
3.9
8.46
8.28
mg/mmol
0.02
43
448
6
40
1.51
0.52
2.2
2.3
—
—
—
0
0
33
271
1.25
0.52
1.5
1.4
—
—
—
0
0
11
154
0.70
0.48
2.1
2.8
—
—
—
0
0
31
255
1.25
0.48
1.4
1.6
—
—
—
0
0
77
692
1.16
0.48
3.0
3.1
35.70
342.75
mg/l
1.12
42
425
207
2137
0.84
0.47
4.5
4.8
4.48
4.68
mmol/l
1.93
193
1968
119
1105
1.14
0.47
3.4
3.9
0.00
0.00
estimate
0.00
23
199
19
148
1.31
0.45
3.4
7.2
—
—
—
0
0
13
95
1.39
0.44
4.8
3.2
—
—
—
0
0
10
139
0.71
0.43
1.0
2.8
4.58
3.77
e9/l
—
10
103
15
194
0.76
0.42
2.9
3.3
—
—
—
0
0
43
373
1.18
0.41
1.2
1.3
44.08
37.85
iu/ml
0.10
12
128
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
117
1094
1.13
0.40
4.6
5.2
0.00
0.00
estimate
0.00
25
207
0
18
0.00
0.40
0.0
2.9
—
34.85
—
0
13
68
614
1.15
0.40
1.6
1.6
1.48
1.38
mmol/l
0.49
59
515
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
31
263
1.20
0.38
1.3
1.3
—
—
—
0
0
17
134
1.29
0.38
4.4
3.3
5.24
5.24
kpa
0.01
17
125
115
1079
1.12
0.36
3.5
3.9
0.00
0.00
estimate
0.00
25
210
47
525
0.87
0.33
1.6
1.5
19.17
21.65
nmol/l
0.64
42
440
96
896
1.11
0.33
1.8
2.0
89.51
96.92
pmol/l
0.95
51
443
155
1484
1.11
0.33
4.2
4.4
—
—
—
0
0
36
315
1.17
0.32
1.5
1.2
—
—
—
0
0
58
528
1.13
0.30
2.2
2.0
3.75
3.36
mg/l
0.18
50
457
23
194
1.20
0.30
1.2
1.3
—
—
—
0
0
7
54
1.30
0.30
1.3
2.0
—
—
—
0
0
65
597
1.12
0.30
4.1
4.0
0.00
0.00
estimate
0.00
21
201
8
66
1.22
0.27
1.3
1.2
—
—
—
0
0
40
441
0.89
0.24
1.7
1.7
1139.33
1226.63
nmol/l
0.23
34
334
31
276
1.14
0.23
1.2
1.3
251.43
466.29
titre
—
7
70
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
83
878
0.92
0.23
2.3
2.6
123.39
119.39
ug/l
0.08
71
799
74
695
1.09
0.22
1.9
2.0
123.93
194.16
u/l
1.36
67
649
27
239
1.14
0.22
1.1
1.4
—
—
—
0
0
10
124
0.80
0.22
1.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
7.4
—
659.30
—
0
10
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
27.90
—
0
10
0
10
0.00
0.21
0.0
11.9
—
1279.70
—
0
10
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
6
49
1.23
0.20
1.5
2.4
—
—
—
0
0
64
605
1.08
0.17
3.4
3.4
—
—
—
0
0
44
471
0.92
0.16
1.3
1.2
1.53
1.34
u/ml
—
6
123
197
2003
0.93
0.16
5.0
4.8
1.71
2.56
mu/l
0.78
180
1801
6
76
0.78
0.16
21.7
11.5
—
—
—
0
0
46
431
1.08
0.15
1.3
1.3
2.49
2.28
g/l
0.38
26
251
142
1386
1.05
0.13
4.6
3.1
70.01
50.02
u/l
0.99
135
1267
15
132
1.14
0.13
2.3
2.5
—
—
—
0
0
20
221
0.90
0.13
5.1
3.9
—
—
—
0
0
12
107
1.13
0.08
1.2
1.2
—
—
—
0
0
6
58
1.04
0.08
3.8
2.4
1.41
1.55
mg/l
—
6
51
13
117
1.12
0.08
1.5
1.4
—
—
—
0
0
14
127
1.11
0.08
1.4
1.2
—
—
—
0
0
7
68
1.03
0.08
1.0
1.2
—
—
—
0
0
52
502
1.04
0.07
3.4
3.9
—
—
—
0
0
7
84
0.83
0.07
1.0
1.3
—
—
—
0
0
175
1730
1.04
0.07
32.5
19.2
329.03
331.54
g/l
3.10
175
1724
12
132
0.90
0.07
1.1
1.2
—
—
—
0
0
11
99
1.12
0.06
1.4
2.1
1.71
1.60
g/l
0.14
11
85
11
120
0.91
0.05
2.3
2.4
0.52
0.70
%
2.07
11
115
69
704
0.97
0.04
4.6
4.0
—
—
—
0
0
45
462
0.97
0.04
3.8
4.2
1.02
1.02
kg/l
—
6
63
213
2118
1.03
0.04
5.0
4.9
6.24
6.00
mmol/l
1.74
197
1917
50
489
1.03
0.03
1.5
1.8
498.08
452.91
pmol/l
0.53
39
397
72
710
1.02
0.02
2.9
2.5
65.71
56.27
u/l
0.47
65
659
204
2048
0.98
0.01
6.4
6.2
41.40
40.41
mmol/mol
0.90
192
1898
74
748
0.99
0.01
3.1
3.2
—
—
—
0
0
10
94
1.07
0.01
3.5
4.4
—
—
—
0
0
14
143
0.98
0.00
1.2
1.5
—
—
—
0
0
36
364
0.99
0.00
1.1
1.2
5.81
9.88
u/ml
0.35
15
139
22
215
1.03
0.00
1.2
1.3
—
—
—
0
0
10
95
1.05
0.00
1.4
1.9
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
7
77
0.91
0.00
1.6
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1363.40
—
0
5
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
6
59
1.02
0.00
1.0
1.3
—
3.25
—
0
15
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
222
2220
1.00
0.00
21.8
13.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
7
71
0.99
0.00
2.7
5.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
7
74
0.94
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
9.0
—
25.80
—
0
6
0
7
0.00
0.00
0.0
2.1
—
2652.71
—
0
7
0
6
0.00
0.00
0.0
1.3
—
18.55
—
0
6
8
81
0.99
0.00
1.7
3.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_LUNG_NEUROENDO – Neuroendocrine tumor and carcinoma of lung

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).